Article ; Online: Identifying cancer patients at risk for cardiotoxicity.
Future oncology (London, England)
2015 Volume 11, Issue 14, Page(s) 2077–2091
Abstract: Improvements in therapies have significantly changed survival of cancer patients. However, the clinical history and oncologic treatment put cancer patients at higher risk for developing cardiovascular problems. Anthracyclines, but also the targeted ... ...
Abstract | Improvements in therapies have significantly changed survival of cancer patients. However, the clinical history and oncologic treatment put cancer patients at higher risk for developing cardiovascular problems. Anthracyclines, but also the targeted therapy and angiogenesis inhibitors, are all treatments associated with cardiotoxicity. The most common adverse event is a reduction in left ventricular ejection fraction that may progress to overt heart failure. Recognition of a cardiac impairment during or after a potential cardiotoxic treatment requires a stringent assessment of clinical symptoms and signs of heart failure associated with an evaluation of the left ventricular ejection fraction, which, however, detects the damage already installed. Circulating cardiac biomarkers are promising in detecting cardiotoxicity and will likely change the approach for identifying patients at risk. |
---|---|
MeSH term(s) | Antineoplastic Agents/adverse effects ; Biomarkers/blood ; Cardiac Imaging Techniques ; Cardiotoxicity/diagnosis ; Cardiotoxicity/etiology ; Cardiotoxicity/genetics ; Female ; Galectin 3/blood ; Genetic Predisposition to Disease ; Humans ; Male ; Natriuretic Peptides/blood ; Neoplasms/complications ; Neoplasms/drug therapy ; Neoplasms/mortality ; Precision Medicine ; Risk Factors ; Troponin T/blood ; Ventricular Dysfunction, Left/chemically induced ; Ventricular Dysfunction, Left/etiology |
Chemical Substances | Antineoplastic Agents ; Biomarkers ; Galectin 3 ; LGALS3 protein, human ; Natriuretic Peptides ; Troponin T |
Language | English |
Publishing date | 2015-07-07 |
Publishing country | England |
Document type | Journal Article ; Review |
ZDB-ID | 2274956-1 |
ISSN | 1744-8301 ; 1479-6694 |
ISSN (online) | 1744-8301 |
ISSN | 1479-6694 |
DOI | 10.2217/fon.15.69 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 6478: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.